UCBG 2-08: 5-year efficacy results from the UNICANCER-PACS08 randomised phase III trial of adjuvant treatment with FEC100 and then either docetaxel or ixabepilone in patients with early-stage, poor prognosis breast cancer
| Image |  |
|---|---|
| Description | scientific article published on 26 September 2018 |
| Author/s |
author: Thomas Bachelot Hans Wildiers |
| Publication date | September 26, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |